Clinical Trial Update: A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety, reactogenicity, and immune response of CureVac's rabies mRNA vaccine in healthy adults; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• CureVac Rabies mRNA vaccine

Snippet

Sponsor: CureVac | Conditions: Rabies | Phase 1 | Status: COMPLETED | Results posted: 2024-12-19